Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 47201-47250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05762146
Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE
PHASE2Recruiting
28 participants
Started: Sep 5, 2022 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05318196
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
N/ARecruiting
5,000 participants
Started: Sep 5, 2022 · Completed: Sep 1, 2032
6 conditions1 sponsor1 location
NCT05413005
Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Type 1 Diabetes Mellitus
EARLY_PHASE1Recruiting
10 participants
Started: Sep 5, 2022 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT05302505
Simulation-based Training for Nurses and Arteriovenous Fistula Puncture in Chronic Hemodialysis Patients
NARecruiting
9,600 participants
Started: Sep 5, 2022 · Completed: Sep 30, 2024
3 conditions1 sponsor9 locations
NCT05536102
The Effectiveness and Safety of XELOX and Tislelizumab + PLD for Resectable Gastric Cancer (LidingStudy)
PHASE2Recruiting
38 participants
Started: Sep 5, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT06194474
Study on Biomarkers of Postoperative Delirium in Elderly Cardiac Surgery Patients
N/ARecruiting
24 participants
Started: Sep 5, 2022 · Completed: Feb 29, 2024
1 condition1 sponsor1 location
NCT05481879
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
PHASE1/PHASE2Recruiting
116 participants
Started: Sep 5, 2022 · Completed: Jul 31, 2029
1 condition1 sponsor9 locations
NCT04972656
Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension
NARecruiting
420 participants
Started: Sep 5, 2022 · Completed: Mar 30, 2026
1 condition2 sponsors1 location
NCT05578196
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
NARecruiting
110 participants
Started: Sep 4, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05555771
Paediatric Syncope in the Emergency Department
NARecruiting
300 participants
Started: Sep 3, 2022 · Completed: Sep 30, 2026
3 conditions4 sponsors1 location
NCT05543954
68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
EARLY_PHASE1Recruiting
60 participants
Started: Sep 3, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05888038
Virtual Reality's Effect on Decreasing Pain and Subsequent Opioid Use in Pediatric Patients in the Post-Operative Period Following Scoliosis Repair
NARecruiting
50 participants
Started: Sep 3, 2022 · Completed: Sep 30, 2024
3 conditions1 sponsor1 location
NCT05303649
Effects of Neuronavigated Theta Burst Stimulation in Therapy of Post-stroke Aphasia
NARecruiting
45 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05464810
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
EARLY_PHASE1Recruiting
40 participants
Started: Sep 2, 2022 · Completed: Apr 15, 2027
6 conditions2 sponsors4 locations
NCT06794203
Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft
N/ARecruiting
100 participants
Started: Sep 2, 2022 · Completed: Jul 1, 2025
3 conditions1 sponsor1 location
NCT05309655
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NARecruiting
90 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2027
3 conditions3 sponsors3 locations
NCT04872790
Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia
PHASE1Recruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2026
5 conditions3 sponsors1 location
NCT05516537
Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.
NARecruiting
100 participants
Started: Sep 2, 2022 · Completed: Aug 31, 2026
1 condition3 sponsors1 location
NCT05377177
Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
NARecruiting
76 participants
Started: Sep 2, 2022 · Completed: Jul 30, 2030
2 conditions2 sponsors1 location
NCT06098781
Gynaecological Gender-affirming Surgeries
N/ARecruiting
57 participants
Started: Sep 2, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05296317
Evaluation and Modeling of the Effect of G-CSF on the Evolution of Polynuclear Neutrophils During Dense Dose Epirubicin-Cyclophosphamide Regeneration
NARecruiting
100 participants
Started: Sep 2, 2022 · Completed: Oct 2, 2025
1 condition1 sponsor1 location
NCT05366166
Pembrolizumab Plus Olaparib in LA-HNSCC
PHASE2Recruiting
45 participants
Started: Sep 2, 2022 · Completed: Oct 31, 2026
1 condition2 sponsors4 locations
NCT05717959
Efficacy of Oropharyngeal Exercises for Patients With Obstructive Sleep Apnea Using Mandibular Advancement Device
NARecruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05480982
Cognitive Functional Therapy Compared With Pilates in Elderly Patients With Chronic Low Back Pain
NARecruiting
200 participants
Started: Sep 2, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05925218
Circulating Tumor DNA Collection From Patients With High Grade Gliomas
N/ARecruiting
70 participants
Started: Sep 2, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT05214222
Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma
PHASE2Recruiting
100 participants
Started: Sep 2, 2022 · Completed: Sep 2, 2028
1 condition1 sponsor1 location
NCT05366179
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PHASE1Recruiting
36 participants
Started: Sep 2, 2022 · Completed: May 30, 2030
1 condition1 sponsor1 location
NCT06726850
Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.
PHASE2Recruiting
129 participants
Started: Sep 2, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT03810768
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
N/ARecruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2026
7 conditions4 sponsors3 locations
NCT05212272
MRI in High-Grade Glioma Patients Undergoing Chemoradiation
NARecruiting
16 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05824871
A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
PHASE3Recruiting
450 participants
Started: Sep 2, 2022 · Completed: Oct 22, 2026
2 conditions1 sponsor2 locations
NCT03824106
Frailty Rehabilitation
NARecruiting
324 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT07024667
Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vaginal Atrophy
NARecruiting
20 participants
Started: Sep 2, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05339698
3D Evaluation to Quantify Regional Volume Change Between FRC and TLC
N/ARecruiting
100 participants
Started: Sep 2, 2022 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT06267781
RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies
N/ARecruiting
30 participants
Started: Sep 2, 2022 · Completed: Sep 2, 2027
1 condition1 sponsor1 location
NCT05624658
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS
NARecruiting
200 participants
Started: Sep 2, 2022 · Completed: May 31, 2024
1 condition2 sponsors1 location
NCT05094570
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
PHASE4Recruiting
20 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05151965
Return to Sport and Functional Performance Following Surgical Intervention for Anterior Glenohumeral Instability
N/ARecruiting
72 participants
Started: Sep 1, 2022 · Completed: Apr 1, 2026
2 conditions1 sponsor1 location
NCT05270902
Haemoadsorption During Heart Transplantation
NARecruiting
40 participants
Started: Sep 1, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05619068
The Evolution and Prognosis of Moyamoya Disease
N/ARecruiting
300 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT06677866
Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder
NARecruiting
20 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05515796
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
PHASE2Recruiting
200 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location
NCT05968729
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
NARecruiting
40 participants
Started: Sep 1, 2022 · Completed: Jul 31, 2027
1 condition2 sponsors1 location
NCT06163612
Effect of Suicidality on Social Cognition
N/ARecruiting
150 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05317221
Developing Breast (Cancer) Organoids
N/ARecruiting
60 participants
Started: Sep 1, 2022 · Completed: May 1, 2028
1 condition3 sponsors1 location
NCT05533892
Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC
PHASE1Recruiting
30 participants
Started: Sep 1, 2022 · Completed: Feb 28, 2025
1 condition10 sponsors1 location
NCT06175416
Spontaneous Pneumothorax in Adolescents
N/ARecruiting
134 participants
Started: Sep 1, 2022 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05521022
Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
PHASE1Recruiting
100 participants
Started: Sep 1, 2022 · Completed: Mar 1, 2025
1 condition2 sponsors11 locations
NCT05432687
Impact of Abdominal Incompetence on Urinary Incontinence After Prostatectomy (PROSTABDO)
NARecruiting
80 participants
Started: Sep 1, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05585255
Clinical Significance of DKK2 Protein in Cerebral Ischemia-reperfusion Injury
N/ARecruiting
108 participants
Started: Sep 1, 2022 · Completed: Sep 30, 2024
3 conditions1 sponsor2 locations